-
Amgen acquires Forbion portfolio company Dezima Pharma
September 17, 2015Amgen acquires Forbion portfolio company Dezima Pharma Upfront payment of USD 300m plus up to USD 1.25bn in development...
0 -
Forbion Portfolio Company News: Dezima
September 12, 2014Dezima Reports Positive Results in its Phase 2b TULIP Trial with CETP Inhibitor TA-8995 in Dyslipidemia Combines outstanding efficacy...
